This compound serves as a key intermediate in the synthesis of proton pump inhibitors (PPIs), such as omeprazole and related derivatives. These medications are widely used to treat gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related disorders by inhibiting the H+/K+ ATPase enzyme in the stomach lining, thereby reducing stomach acid production and providing long-lasting suppression. Valued for its reactivity and specificity, it enables high-yield, selective transformations in the final stages of pharmaceutical manufacturing.